| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
3171 |
| issn |
0960-894X |
| issueIdentifier |
9 |
| pageRange |
3168-3171 |
| publicationName |
Bioorganic & medicinal chemistry letters |
| startingPage |
3168 |
| bibliographicCitation |
Jacob JN, Tazawa MJ. Glucose–aspirin: Synthesis and in vitro anti-cancer activity studies. Bioorganic & Medicinal Chemistry Letters. 2012 May;22(9):3168–71. doi: 10.1016/j.bmcl.2012.03.053. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad21010c1b875c685ce76147651c5a7f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c46acd8300f963209121e19397f5c23 |
| date |
2012-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1016/j.bmcl.2012.03.053
https://pubmed.ncbi.nlm.nih.gov/22494617 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0960-894X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20409 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Glucose–aspirin: Synthesis and in vitro anti-cancer activity studies |
| discusses |
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0586750
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0009339
http://id.nlm.nih.gov/mesh/M0016225
http://id.nlm.nih.gov/mesh/M0009358 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 |